Word-of-mouth and clinical evidence are not the same
Over twenty acne products line a typical pharmacy shelf. The drugs most popularly rumored as "the best for acne" online do not always match the ones backed by large randomized trials. "Used widely and for a long time" is not the same as "evidence-rich."
This article has three goals: (1) honestly distinguish which active ingredients in OTC acne products have randomized controlled trial (RCT) or meta-analysis level evidence; (2) clarify when OTC products are sufficient; (3) define when ointments hit their limit and dermatology consultation is preferred.
Why one ointment cannot solve all acne
Acne involves four pathophysiologic mechanisms acting simultaneously: sebaceous gland hyperactivity (androgen-driven sebum overproduction), follicular hyperkeratinization (clogged pores forming comedones), Cutibacterium acnes proliferation, and the resulting inflammatory response.
Each agent targets a different stage; no single agent addresses all four. The 2024 American Academy of Dermatology (AAD) acne guidelines state that "no single agent fully targets all four mechanisms; combination therapy remains standard." This is why no OTC ointment alone resolves every type of acne.
Strongest OTC evidence — Benzoyl Peroxide (BPO)
If forced to name one OTC ingredient with the strongest evidence base, it is Benzoyl Peroxide (BPO). BPO generates reactive oxygen species that directly kill C. acnes, dissolves keratin to unblock pores, and — crucially — does not create antibiotic resistance, unlike topical antibiotics.
The 2024 AAD guidelines rated BPO with a strong recommendation, the highest tier among ingredients available without prescription. Notably, a 12-week RCT comparing OTC BPO 2.5% + retinoid versus prescription high-concentration BPO + antibiotic + retinoid showed statistically similar outcomes between groups — challenging the perception that "only prescription combos work."
How to use BPO — stepwise adaptation reduces irritation
- Weeks 1–2 adaptation: apply a small amount to lesions only at bedtime, then expand to morning and evening.
- Sandwich application: mix with moisturizer or use a retinoid-style sandwich layering.
- Early erythema and stinging: often adaptation rather than worsening.
- Bleaching warning: can bleach clothes, towels, and hair; use white pillowcases and towels.
- Sunscreen is mandatory: photosensitivity rises; SPF 50+ daytime sunscreen is essential.
Concerns about benzene contamination circulated in past years, but a 2025 JAAD study found no significant association between BPO use and benzene-related cancer. Avoiding heat exposure of products is the only practical precaution.
For acne plus pigmentation — Azelaic Acid
If you have post-inflammatory red or brown marks alongside active acne, azelaic acid is worth a look. It addresses three of the four pathophysiologic mechanisms — bactericidal action against C. acnes, normalization of follicular keratinization, and anti-inflammation. It additionally inhibits tyrosinase, supporting improvement of post-inflammatory hyperpigmentation (PIH).
2024 AAD gives a conditional recommendation. A 2023 RCT showed significant pigmentation index reduction at week 12. A 2020 Cochrane review rated azelaic acid slightly below BPO but comparable to tretinoin and topical antibiotics.
A 2024 split-face study found azelaic acid and BPO routines produced statistically equivalent total lesion reduction at 12 weeks (p=0.97), with better tolerability and patient preference for azelaic acid. It is also classified as relatively safe in pregnancy — but never self-decide; consult a physician.
For comedones — Salicylic Acid
For non-inflammatory comedonal acne (whiteheads, blackheads, papules without inflammation), salicylic acid 2% is a reasonable starter. Lipophilic and pore-penetrating, it dissolves keratin within follicles to unblock comedones.
2024 AAD gives conditional recommendation. Safe and well tolerated for beginners, but evidence tier remains one step below BPO. For moderate-to-severe inflammatory acne, salicylic acid alone is insufficient — add BPO or seek dermatology consultation.
The popular IPMP combination — limited evidence
For inflamed pustular acne, Korean pharmacies often recommend ibuprofen piconol + isopropyl methylphenol (IPMP) combinations. These act by blocking the C. acnes growth environment and reducing inflammation, with the advantage of no antibiotic resistance concern and low irritation — practical for sensitive skin first-trials.
But evidence is candidly limited: clinical data is mostly small-scale open trials; no large RCTs or AAD guideline mention exist. Reasonable as an entry-level option, but if effect is not clear, transition to BPO or another evidence-rich choice should be considered early.
Sulfur and Tea Tree Oil — does evidence match the buzz?
Both have a "natural and gentle" reputation, but evidence weight differs from the ingredients above.
Sulfur has long-known keratolytic and antibacterial action, but the 2020 Cochrane review rated its efficacy as "uncertain." Paradoxical comedogenicity has also been reported. Brief use for pustular flares may help, but long-term use in comedone-prone skin requires caution.
Tea tree oil fares slightly better. Small RCTs document efficacy in mild-moderate acne. Direct comparison with BPO showed similar efficacy but slower onset, with lower irritation. A reasonable alternative for sensitive skin that cannot tolerate BPO. Allergic contact dermatitis is reported in 5–10%, so concentrated standalone use is best replaced with adjuvant formulations.
For post-acne marks
Red or brown marks left after acne resolves require a different approach. Pharmacies often offer scar-care ointments containing heparin sodium, allantoin, and dexpanthenol. These raise hydration in scar tissue, support collagen reorganization, and accelerate skin regeneration.
If red marks are progressing to true hyperpigmentation, combining azelaic acid is worthwhile. The marks-care product and pigmentation-targeting azelaic acid are not competitors but complements at different stages.
Post-extraction care — regeneration phase
For oozing wounds immediately after pimple extraction, prevention of infection and regeneration come first. Centella asiatica creams and antibiotic regeneration ointments are used here. A staged approach — short-course antibiotic ointment for the first 1–2 days, then transition to centella regeneration cream once the wound stabilizes — works well.
Important caveats: regeneration ointments applied too thickly can delay healing; never apply them onto active pustular lesions; antibiotic ointments should be limited to under 1–2 weeks to avoid resistance.
Common mistake — layering strong actives
A frequent clinic presentation is skin "flipping" from layering several strong actives. Combining BPO with strong retinol cosmetics, or salicylic acid with exfoliating toners, can trigger explosive irritation.
The fix: stop everything for 2–3 days and use only moisturizer; restart one product at a small dose once skin calms. Another common error is misjudging the acne type — applying pustular drugs to comedones, or comedone drugs to inflamed pustules, simply does not work. Many also forget sunscreen: BPO, salicylic acid, and azelaic acid all increase photosensitivity, and skipping SPF makes marks darken further.
When OTC has reached its limit — the 6-week rule
If consistent 6+ weeks of OTC use produces no improvement, that is the signal of topical therapy hitting its ceiling. Nodulocystic acne, deep painful lesions, simply cannot be reached physically by topical BPO or salicylic acid.
Widespread involvement of face and trunk, or hormonal patterns following the jawline recurring with menstrual cycles, indicate causes beyond what topical drugs control. These suggest hormonal evaluation may be warranted.
Most critically, once scars start to set, time matters. Scars are difficult to reverse with ointments once established, and early management opportunity passes into the procedure realm. Actively calming acne before scars form is, often, the most cost-effective long-term choice.
OTC Acne Treatment Comparison at a Glance
| Ingredient | Primary Indication | AAD Evidence | Irritation | Onset |
|---|---|---|---|---|
| Benzoyl Peroxide 2.5% | All acne types | Strong Recommendation | High | 2–4 weeks |
| Azelaic Acid 20% | Acne + pigmentation | Conditional | Low–moderate | 4–12 weeks |
| Salicylic Acid 2% | Comedonal (non-inflammatory) | Conditional | Moderate | 2–4 weeks |
| IPMP combination | Pustular (inflammatory) | Small open trials | Low | 1–2 weeks |
| Heparin + Allantoin + Dexpanthenol | Red marks · scar care | Multiple scar RCTs | Very low | 4–12 weeks |
| Centella asiatica | Post-extraction regeneration | Reviews & RCTs present | Very low | Immediate–2 weeks |
Closing — the 6-week threshold and consultation
In the clinic, most patients had not chosen the wrong drug — they had followed online buzz without identifying their own acne type first. Distinguishing comedonal vs pustular, active vs post-acne marks, dramatically shortens pharmacy trial-and-error.
Use 6 weeks as the threshold: if no change after 6 weeks of consistent use, do not keep struggling alone — get evaluated. Changing direction before scars set is often the wisest choice. ABLE Dermatology in Songpa, Seoul is 2 minutes on foot from Exit 4 of Police Hospital Station; a board-certified Korean dermatologist provides direct consultation, diagnosis, and treatment in English.
If 6+ weeks of OTC treatment has not improved your acne, consult a board-certified dermatologist. Book a consultation to start with an accurate diagnosis.